Pharmaceutical Filtration Market: Current Analysis and Forecast (2022-2028)

Pharmaceutical Filtration Market: Current Analysis and Forecast (2022-2028)

Pharmaceutical filtration is a separation method in which a porous medium is used in the process of filtering to remove solid particles from a fluid, which can be either liquid or gas. Because of its versatility, filtration is frequently utilized in the pharmaceutical sector to meet a wide range of applications such as final product processing, water purification, air purification, raw material filtration, and others. One of the main drivers of the pharmaceutical filtration industry's expansion is the rise of chronic diseases on a global scale. As per CDC, in 2022, 6 in 10 adults in the US have a chronic disease. Thus, advanced therapeutic medications are in high demand for the treatment of chronic illnesses like cancer, diabetes, asthma, COPD, and arthritis. Furthermore, the creation of unique biologics needs absolute sterility and zero risk of contamination, which makes the use of modern filtering technologies for the production of pharmaceuticals and biologics even more necessary.

The Pharmaceutical Filtration Market is expected to grow at a steady rate of around 14% owing to the rising generic medication production and the growing requirement for clean and safe research and manufacturing environment. Major companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches. For instance, In October 2021, 3M Health Care and Thermo Fisher Scientific collaborated to increase process efficiency and scalability in commercial therapeutic manufacturing.

• Based on product, the market is segmented into membrane filters, prefilters & depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and others. The membrane filters category is to witness significant CAGR during the forecast period. This is mainly due to the rise in demand for good manufacturing practices (GMP) and single-use technologies in the pharmaceutical industry. Membrane filtration is a method of separating particles in liquid solutions or gas mixtures. This technique is used in a wide range of applications ranging from dairy processing to wastewater treatment.
• On the basis of technique, the market is categorized into microfiltration, ultrafiltration, nanofiltration, and others. Among these, microfiltration held a significant share of the market in 2020. Microfiltration is a crucial and popular technique for eliminating whole cells, cell fragments, and colloids from bacterial and mammalian fermentation broths. This is an essential step in the creation and manufacturing of biopharmaceuticals in the filtration process.
• Based on application, the pharmaceutical filtration market has been classified into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing category held a significant share in 2020. This is mainly due to the surge in the use of filters in the protein purification process, vaccine processing, virus clearance, and antibody processing, active pharmaceutical component processing.
• Based on the scale of operation, the pharmaceutical filtration market has been classified into manufacturing scale, pilot scale, and R&D scale. The manufacturing scale held a significant share in 2020. This is mainly due to the rising production of biopharmaceuticals, generic medicines, and vaccines which are utilized for the treatment of chronic disorders.
• For a better understanding of the market adoption of the pharmaceutical filtration industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to a rise in investments in the pharmaceutical and biopharmaceutical industry. For instance, in 2022, Merck enters into an agreement with the administrative management committee of the Wuxi National High-tech Industrial Development Zone. According to the agreement, the industry giant will expand its single-use manufacturing center in Wuxi, East China's Jiangsu province. Growing biologics and active pharmaceutical ingredient (API) output accelerating healthcare reforms, and a highly developed healthcare system all contribute to market expansion in China. In addition, the demand for cutting-edge medical facilities is expected to rise as the population grows. This will also result in more R&D being done in the pharmaceutical industry.
• Some of the major players operating in the market include Merck KGaA, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., 3M, Eaton Corporation PLC, Amazon Filters Ltd., Graver Technologies, LLC, Meissner Filtration Products, Inc.